A world-first clinical trial launched in Australia is being hailed a ‘game-changer’ for its potential to revolutionise the ...

Sarah Nash of the Iowa Cancer Registry and Kelly Wells Sittig of the Iowa Cancer Consortium on the "Iowa Press" set. (Iowa ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light Cystoscopy (BLC®), notably its impact on management ...

Nearly 80% of patients who suffered from a variety of cancer types were successfully treated with only immunotherapy, according to a new study published in The New England Journal of Medicine.

These are commonly mutated cancer-causing genes that drive the formation of many types of tumors, including pancreatic cancer. This study evaluated the effectiveness of RMC-6236 in patient-derived ...

Previous MSK research found PSG genes are activated in about 20% of patients with lung, breast, uterus, and colon cancer, and that these patients generally had worse outcomes. The new study builds ...

Using ctDNA test results to guide adjuvant treatment with pembrolizumab can provide benefits in patients with dMMR solid tumors, data suggest.

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations.